News | May 13, 2021
Torrent Pharma enters into agreement with Lilly for Baricitinib for Covid-19 in India
The agreement will help ensure wider reach and access to patients in India
The agreement will help ensure wider reach and access to patients in India
The deal is to sell one of the two business undertakings of ZAHL for a lump sum consideration of Rs. 2921 crores on a cash free and debt free basis,
Baricitinib was issued a restricted emergency use approval by the Central Drugs Standard Control Organization (CDSCO)
Much-needed diagnostics supplies will help accelerate testing capabilities of hospitals and clinics across India
The Government of India has started importing the vital drug Remdesivir from other countries to ease out the shortage of Remdesivir in the country
Riding COVID-19 wave, Indian vaccine industry set to be Rs. 700 billion strong
Essential medicines were made available to more than 150 countries around the world during the pandemic
Report outlines the wide array of investment opportunities in various segments of India’s healthcare sector
The receipt of this permission paves way for the launch of Osimertinib 40mg/80mg film coated tablets in India.
The next phase of growth in pharma depends on the industry-oriented workforce, risk investment, academic revamp, and creation of R&D hubs, say experts .
Subscribe To Our Newsletter & Stay Updated
